HPV Infection and Vaginal Microecology in Immunosuppressed Women
NCT ID: NCT06619743
Last Updated: 2024-10-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
10000 participants
OBSERVATIONAL
2024-10-01
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gut and Vaginal Microbiota Profile Study for HIV Women
NCT05996016
Persistent Cervical HPV Infection With Clearance and Vaginal Microbiota
NCT03895866
The Predictive Role of HPV Integration in HSIL and Cervical Cancer
NCT05300243
Evaluation of Triage Options After HPV Testing for Cervical Cancer Screening Among HIV-infected Women
NCT03789513
Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV
NCT04974424
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HIV infection is sexually transmitted
* Have an intact cervix
* Have not received cervical cancer screening in the past 1 year
* No previous treatment for CIN/cervical cancer
* No clinical pregnancy symptoms
Exclusion Criteria
* Unable to complete all screening processes independently
* Unable or unwilling to accept follow-up
* For subjects in vaginal microecology studies, women who used antibiotics within 2 weeks before collecting vaginal secretions, had sexual intercourse within 3 days, or used vaginal medication or vaginal douching within 48 hours need to be further excluded.
18 Years
75 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lan Zhu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lan Zhu
Director of the Department of Obstetrics and Gynecology at Peking Union Medical College Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
K6758
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.